The Israel Institute for Biological Research (IIBR) has tapped technology by Dyadic International in its research efforts to find a treatment for coronavirus. The IIBR will explore the Jupiter-based biotechnology company's (Nasdaq: DYAI) C1 method as a means of both speeding up and reducing the cost of the global distribution of a potential vaccine or cure for the deadly virus.